|
 |
Curriculum Vitae
Current Position:
Interventional Cardiologist and Endovascular Specialist
Orlando Heart Specialists
Orlando, Florida
Chief of Cardiology
Orlando Regional Medical Center – South Seminole Hospital
Orlando, Florida
Director of Cardiac Catheterization Laboratory
Florida Hospital Altamonte
Orlando, Florida
Hospital Affiliation:
Florida Hospital
Orlando, Fl
Orlando Regional Medical Center
Orlando, Fl
Education:
Post Graduate:
Albert Einstein College of Medicine / Montefiore Medical Center
Interventional Cardiology Fellow
Bronx, New York
July 2001-June 2002
Albert Einstein College of Medicine / Montefiore Medical Center
Chief Cardiology Fellow
Bronx, New York
July 1998- June 2001
The New York Presbyterian Hospital-Weill Cornell Medical Center
Residency in Internal Medicine
New York, New York
July 1995 – June 1998
Memorial Sloan-Kettering Cancer Center
Intern and Resident
New York, New York
July 1995 – June 1998
Graduate:
Albert Einstein College of Medicine
Degree: Doctor of Medicine with Special Distinction For Research in Cardiovascular Medicine
Bronx, New York
September 1991 – June 1995
Undergraduate:
New York University
College of Arts and Science, Senior Class Representative
Major: Languages and Literatures and Pre-Medical Sciences
Degree: Bachelor of Arts; Cum Laude with Honors in Languages and Literatures
New York, New York
September 1988 – June 1991
Lycee Internationale de Valbonne
Degree: International Baccalaureate of Geneva
Valbonne, France
September 1984 - June 1988
Certificates:
Diplomate of the American Board of Internal Medicine
November 4, 1998
Diplomate Number: 181939
Medical Licensure:
State of Florida
License Number: ME84848
Status: Active
State of New York
License Number: 206125
Status: Inactive
Professional Organization Membership:
American College of Cardiology
Fellow
American Heart Association
Council Member
The Alpha Omega Alpha Honor Medical Society
Member
Society for Cardiac Angiography and Interventions
Member
Honors and Awards:
August 2000 Cardiology Fellows Scholarship Recipient
AVENTIS AHA 2000 Scholarship
Research and Publications Papers:
1. Wilson SR, Vakili BA, Sherman W, Sanborn TA, Brown DL. Effect of diabetes on long term mortality following contemporary percutaneous coronary intervention: Analysis of 4,284 cases. Diabetes Care 2004; 25 (5):1137-42.
2. Brown DL, Desai KK, Vakili BA, Nouneh C, Lee HM, Golub LM. Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndrome (MIDAS) pilot trial. Arterioscler Thromb Vasc Biol 2004; 24 (4): 733-8.
3. Babak A. Vakili and David L. Brown MD. Relation of Total Annual Coronary Angioplasty Volume of Physicians and Hospitals on Outcomes of Primary Angioplasty for Acute Myocardial Infarction. Am J Cardiol 2003;91:726-728.
4. Babak A. Vakili, Kaplan RC, Slater JN, Sherman W, Ravi KL, Green SJ, Sanborn TA, Brown DL. A propensity analysis of the impact of platelet glycoprotein IIb/IIIa inhibitor therapy on in-hospital outcomes after percutaneous coronary intervention. Am J Cardiol. 2003 Apr 15;91(8):946-50
5. V.S. Srinivas MBBS, Babak A. Vakili MD, David L. Brown. Comparison of In-Hospital Outcomes Following Early or Delayed Angioplasty for Acute Myocardial Infarction. J Invasive Cardiol 14 (12):746–750, 2002.
6. Babak A. Vakili MD, Robert C. Kaplan PhD, James N. Slater MD, Warren Sherman MD, Kumar L. Ravi MD, Stephen J. Green MD, Timothy A. Sanborn MD, and David L. Brown MD. A Propensity Analysis of the Impact of Platelet Glycoprotein IIb/IIIa Inhibitor Therapy on In-Hospital Outcomes After Percutaneous Coronary Intervention. Am J Cardiol 2003;91:946-950.
7. Olga Dynina, Babak A. Vakili MD, James N. Slater MD, Warren Sherman MD, Kumar L. Ravi MD, Stephen J. Green MD, Timothy A. Sanborn MD and David L. Brown MD. In Hospital Outcomes of Contemporary Percutaneous Coronary Interventions in the Very Elderly. Cathet Cardiovasc Intervent 2003; 58:352-357.
8. Babak A. Vakili MD, Robert Kaplan and David L. Brown MD. Volume-Outcome Relation for physicians and Hospitals Performing Angioplasty for Acute Myocardial Infarction in New York State. Circulation, Oct 2001, 104:2171-2176.
9. Babak A. Vakili MD, Robert Kaplan and David L. Brown MD. Sex-Based Differences in Early Mortality of Patients Undergoing Primary Angioplasty for First Acute Myocardial Infarction. Circulation. 2001;104:3034-3038.
10. Babak A. Vakili MD, Peter Okin MD, Richard B. Devereux. The Forty-Year Review of the Prognostic Implications of Left Ventricular Hypertrophy. American Heart Journal, 2001;141:334-41.
11. Babak A. Vakili MD and David L. Brown MD. In-Hospital Outcomes Following Percutaneous Transluminal Coronary Angioplasty Versus Stent Placement for Acute Myocardial Infarction. Am J Cardiol, Nov 1 2000, 86(9): 998-1000.
12. Babak A. Vakili MD and William H. Frishman MD. Antioxidant Vitamins and Enzymatic and Synthetic Oxygen-Derived Free Radical Scavengers in the Prevention and Treatment of Cardiovascular Disease. Heart Disease, 2001;3:28-45.
Abstracts:
1. Babak A. Vakili MD, H Babburi, A. Ilercil and J. Shirani MD. Power Motion Imaging Improves Assessment of Left Atrial Appendage by Transesophageal Echocardiography. J Invest Med March 2003; 51: Suppl 2: 28.
2. Diosdado M. Irlandez MD, Babak A. Vakili MD, Warren Sherman MD, Kumar L. Ravi MD, Timothy A. Sanborn MD and David L. Brown MD. Effect of Creatine Kinase Elevation Following Percutaneous Coronary Intervention on Long-Term Mortality. J Am Coll Cardiol March 2003; 1029-192:11A
3. Babak A. Vakili MD, Warren Sherman MD, Kumar L. Ravi MD, Timothy A. Sanborn MD and David L. Brown MD. Impact of Chronic Renal Insufficiency on Long term Survival Following Percutaneous Coronary Intervention. J Am Coll Cardiol March 2003; 1127-195:47A
4. Jeffrey S. Berger MD, Babak A. Vakili MD, Timothy A. Sanborn MD, Warren Sherman MD, Kumar L. Ravi MD and David L. Brown MD.
Gender Based Differences in Long Term Outcome Following Percutaneous Coronary Intervention. J Am Coll Cardiol March 2003; 1127-190:46A
5. Babak A Vakili, David L Brown, Beth Israel Medical Ctr, New York, NY
Short-Term Outcomes of Abciximab Treatment during Stent Placement for
Acute Myocardial Infarction: A Meta-Analysis of Randomized Clinical Trials American Heart Association Meeting November 2002
6. Babak A Vakili, Warren Sherman, Kumar L Ravi, Timothy A Sanborn,
David L Brown, Beth Israel Medical Ctr, New York, NY, Impact of Glycoprotein IIb/IIIa Inhibitors on Long-Term Survival Following Administration during Primary Angioplasty for Acute Myocardial Infarction. American Heart Association Meeting November 2002
7. Kavita Desai, Babak A Vakili, Chadi Nouneh, Montefiore Medical Ctr, Bronx, NY; Hsi-Ming Lee, SUNY Stony Brook, Stony Brook, NY; Lorne M Golub, SUNY Stony Brook, Stony Brook, OK Clinical and Biochemical Results of the Metalloproteinase Inhibition with Low-Dose Doxycycline to Prevent Acute Coronary Syndromes (MIDAS) Pilot Trial David L Brown, Beth Israel Medical Ctr, New York, NY. American Heart Association Meeting November 2002
8. Babak A. Vakili MD and David L. Brown MD. Influence of Gender on In-Hospital Outcomes of Patients Undergoing Primary Percutaneous Coronary Angioplasty for Acute Myocardial Infarction. J Am Coll Cardiol February 2000;35;2:11A
9. Babak A. Vakili MD and David L. Brown MD. In-Hospital Outcomes Following Percutaneous Coronary Angioplasty Versus Stent Placement for Acute Myocardial Infarction. J Am Coll Cardiol February 2000;35;2:12A
10. M. S. Berlowitz MD, V. S. Srinivas MD, Babak. A. Vakili MD and David L. Brown MD. Percutaneous Transluminal Coronary Angioplasty of Protected Versus Unprotected Left Main Coronary Arteries. J Am Coll Cardiol February 2000;35;2:72A.
11. Babak A. Vakili MD and David L. Brown MD. Operator and Hospital Volume-Outcome Relation in Patients with Acute Myocardial Infarction Treated with Primary Angioplasty. Circulation October 2000;102;18;II-386.
12. Babak A. Vakili MD, Richard B. Devereux, Mary J. Roman & M. H. Alderman. Relationship of Plasma Renin Activity to Left Ventricular Function in Normotensive and Hypertensive Employed Adults. Circulation October 2000;102;18;II-606.
13. Babak A. Vakili MD, Stephen J. Green MD, Kumar L. Ravi MD, Warren Sherman MD, Timothy A. Sanborn MD, James N. Slater MD and David L. Brown MD. Effect of Diabetes Mellitus on Outcomes of Contemporary Percutaneous Interventions. Circulation October 2000;102;18;II-643.
14. Olga Dynina, Babak A. Vakili MD, James N Slater MD, Warren Sherman MD, Kumar L Ravi MD, Stephen J Green MD, Timothy A Sanborn MD, David L Brown MD. Percutaneous Coronary Interventions in the Very Elderly Are Not Associated with Age-Specific Increases in Mortality. (Accepted AHA 2001).
15. Babak A. Vakili MD, Robert Kaplan PhD, James N Slater MD, Warren Sherman MD, Kumar L Ravi MD, Stephen J Green MD, Timothy A Sanborn MD, David L Brown MD. GP IIb/IIIa InhibitorTreatment for Percutaneous Coronary Intervention Is Associated with an Increased Risk of Post-procedure Myocardial Infarction. (Accepted AHA 2001).
16. Babak A. Vakili MD and David L Brown MD. The ACC/AHA PTCA Volume Guidelines for Physicians and Hospitals Do Not Predict Outcome Following Primary Angioplasty for Acute Myocardial Infarction. (Accepted AHA 2001).
17. Sean R. Wilson BA, Babak A. Vakili MD, Warren Sherman MD, Kumar L. Ravi MD, Timothy A. Sanborn MD and David L. Brown. Impact of diabetes on out-of-hospital survival following percutaneous coronary intervention: A case control study. J Am Coll Cariol March 2002; 844-4;48A .
18. Babak A. Vakili MD, James N Slater MD, Warren Sherman MD, Kumar L Ravi MD, Stephen J Green MD, Timothy A Sanborn MD, David L Brown MD. Impact of peripheral vascular disease on in-hospital outcomes following percutaneous coronary intervention. J Am Coll Cariol March 2002; 1148-2;49A .
19. Babak A. Vakili MD, James N Slater MD, Warren Sherman MD, Kumar L Ravi MD, Stephen J Green MD, Timothy A Sanborn MD, David L Brown MD. Effect of treatment with platelet glycoprotein IIb/IIIa inhibitors on in-hospital outcomes of patients treated with primary angioplasty for acute myocardial infarction. J Am Coll Cariol March 2002; 1123-44;309A .
20. Mauro Moscucci, Kim A. Eagle, David Share, Anthony C. DeFranco, Babak A. Vakili, Vivian L. Clark, James N. Slater, Warren Sherman, Kumar L. Ravi, Timothy A. Sanborn, Stephen J. Green, David L. Brown. Public Reporting and Case Selection for Percutaneous Coronary Interventions: AN Analysis from two large multicenter PCI databases. J Am Coll Cariol March 2002; 1024-168;436A .
Books:
1. Nathan A. Kruger MD, William H. Frishman MD, Devraj U. Nayak MD and Babak A. Vakili MD. Antioxidant Vitamins and Enzymatic and Synthetic Oxygen Derived Free Radical Scavengers and Treatment of Cardiovascular Disease. In Frishman WH, Sonnenblick EH, Sica D (eds): Cardiovasculat Pharmacotherapeutics 2nd ed. New York: McGraw-Hill, 2002 in press.
2. Babak A. Vakili MD and David L. Brown MD. Effect of Lipid Lowering on Coronary Plaque Stabilization. In Cardiovascular Plaque Rupture. Marcel Dekker, New York, NY, 2002, pp 377-398.
Audio Tapes:
1. Babak A. Vakili MD. Early Detection of Cardiovascular Disease in Women. Cortlandt Communications. New York, New York, 2000.
2. Babak A. Vakili MD. Operator and Hospital Volume-Outcome Relation in Patients with Acute Myocardial Infarction Treated with Primary Angioplasty. ACCEL February 2001. Tape 1. Side A.
|
 |